Clinical Trial Details


Research Study Summary

Phase 3b Golimumab Multicenter, Switch Assessment of Subcutaneous and Intravenous Efficacy in Rheumatoid Arthritis Patients who have Inadequate disease control despite treatment with Etanercept (Enbrel) or Adalimumab (Humira)


Do you have Rheumatoid arthritis? You may qualify to participate in a clinical research study.

GOLIMUMAB- Research continues on the use of this TNF inhibitor with two trials available -one for biologic naïve patients and a second for biologic nonresponders. The biologic nonresponders are randomized to delivery systems, so all participating patients will have the benefit of a TNF inhibitor. This is a unique opportunity for patients without insurance to receive this class of therapies.

To Learn more

CW ID: 169937
Date Last Changed: July 23, 2013

Clinical Trial Snapshot

Both Male and Female
Overall Status
Facility Type


The Center for Rheumatology and Bone Research
2730 University Blvd West, Suite 306
Wheaton, MD 20902
Phone: 301 942-6610
Fax: 301 942-7833

View Map

Research Center Information:

The Center for Rheumatology and Bone Research

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.